Literature DB >> 11138406

New concepts of the etiopathogenesis and treatment of insulin-dependent diabetes mellitus.

J F Bach1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11138406     DOI： 10.1385/CRIAI:19:3:217

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN： 1080-0549            Impact factor:   8.667


× No keyword cloud information.
  35 in total

1.  Genetics of insulin-dependent diabetes; non-major histocompatibility genes.

Authors:  T R Merriman; J A Todd
Journal:  Horm Metab Res       Date:  1996-06       Impact factor: 2.936

2.  Epidemiology of childhood IDDM in Northern Ireland 1989-1994: low incidence in areas with highest population density and most household crowding. Northern Ireland Diabetes Study Group.

Authors:  C C Patterson; D J Carson; D R Hadden
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

3.  Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus.

Authors:  J Silverstein; N Maclaren; W Riley; R Spillar; D Radjenovic; S Johnson
Journal:  N Engl J Med       Date:  1988-09-08       Impact factor: 91.245

4.  Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse.

Authors:  A Herbelin; J M Gombert; F Lepault; J F Bach; L Chatenoud
Journal:  J Immunol       Date:  1998-09-01       Impact factor: 5.422

Review 5.  Are there unique autoantigens triggering autoimmune diseases?

Authors:  J F Bach; S Koutouzov; P M van Endert
Journal:  Immunol Rev       Date:  1998-08       Impact factor: 12.988

Review 6.  Role of viruses in the pathogenesis of IDDM.

Authors:  J W Yoon
Journal:  Ann Med       Date:  1991-10       Impact factor: 4.709

7.  Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.

Authors:  D L Kaufman; M Clare-Salzler; J Tian; T Forsthuber; G S Ting; P Robinson; M A Atkinson; E E Sercarz; A J Tobin; P V Lehmann
Journal:  Nature       Date:  1993-11-04       Impact factor: 49.962

8.  Peptide therapy for diabetes in NOD mice.

Authors:  D Elias; I R Cohen
Journal:  Lancet       Date:  1994-03-19       Impact factor: 79.321

9.  Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription.

Authors:  A Muir; A Peck; M Clare-Salzler; Y H Song; J Cornelius; R Luchetta; J Krischer; N Maclaren
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

10.  Viruses as therapeutic agents. II. Viral reassortants map prevention of insulin-dependent diabetes mellitus to the small RNA of lymphocytic choriomeningitis virus.

Authors:  M B Oldstone; R Ahmed; M Salvato
Journal:  J Exp Med       Date:  1990-06-01       Impact factor: 14.307
View more
  3 in total

Review 1.  The role of immunomodulation therapy in autoimmune diabetes.

Authors:  Johnny Ludvigsson
Journal:  J Diabetes Sci Technol       Date:  2009-03-01

2.  Type 1 renal tubular acidosis in a patient of Type 1 diabetes mellitus: Is it coincidence or coexistence?

Authors:  Muzafar Naik; Tariq Bhat; Mubarik Naqash; Manzoor Wani; Nazir Dar; Younis Shah
Journal:  Indian J Endocrinol Metab       Date:  2012-03

3.  Cardiac Mitochondrial Respiratory Dysfunction and Tissue Damage in Chronic Hyperglycemia Correlate with Reduced Aldehyde Dehydrogenase-2 Activity.

Authors:  Vishal R Mali; Guodong Pan; Mandar Deshpande; Rajarajan A Thandavarayan; Jiang Xu; Xiao-Ping Yang; Suresh S Palaniyandi
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.